Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 16/1/2019
SIETES contiene 92637 citas

 1 a 20 de 20 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Anónimo. Cannabinoids: just like any other medication?. Lancet 2018;392:21 de julio. [Ref.ID 102744]
2. Cita con resumen
Joseph A. FDA approves country’s first medicine made from marijuana. STAT Daily Recap 2018:2. [Ref.ID 102664]
3.Enlace a cita original Cita con resumen
Devinsky O, Patel AD, Cross JH, Villanueva V, Wirrell EC, Privitera M, Greenwood SM, Roberts C, Checketts D, VanLandingham KE, Zuberi SM, for the GWPCARE3 Study Group. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med 2018;378:17 de mayo. [Ref.ID 102609]
4. Cita con resumen
Joseph A. Panel recommends FDA approval of epilepsy drug derived from marijuana. DIA Daily 2018:1. [Ref.ID 102518]
6.Tiene citas relacionadas Cita con resumen
Varadkar S. Cannabidiol for drop seizures in Lennox-Gastaut syndrome. Lancet 2018;391:1006-7. [Ref.ID 102474]
7.Tiene citas relacionadas Cita con resumen
Thiele EA, French ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, Lyons PD, Taylor A, Roberts C, Sommerville K, on behalf of the GWPCARE4 Study Group. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2018;391:24 de enero. [Ref.ID 102450]
10. Cita con resumen
Anónimo. Rufinamide. Prescrire 2014;34:336. [Ref.ID 97557]
11. Cita con resumen
Anónimo. Clobazam (Onfi) for Lennox-Gastaut syndrome. Med Lett Drugs Ther 2012;54:18-9. [Ref.ID 92502]
Miselli M. Rufinamide. Informazioni sui Farmaci 2009;33:13-5. [Ref.ID 85750]
13. Cita con resumen
Anónimo. Rufinamide (Banzel) for epilepsy. Med Lett Drugs Ther 2009;51:18-20. [Ref.ID 85522]
14. Cita con resumen
Anónimo. Enrichir sa panoplie thérapeutique. Bilan de l'année 2008. Neuro-psychiatrie. Prescrire 2009;29:44-6. [Ref.ID 84819]
15. Cita con resumen
Anónimo. Topiramate. Warning about metabolic acidosis. WHO Pharmaceuticals Newsletter 2004;1:8. [Ref.ID 69607]
16. Cita con resumen
Ormond D, McClellan k. Topiramate: a review of its use in childhood epilepsy. Paediatr Drugs 2001;3:293-319. [Ref.ID 56527]
Schmidt D, Bourgeois B. A risk-benefit assessment of therapies for Lennox-Gastaut syndrome. Drug Saf 2000;22:467-77. [Ref.ID 51344]
18. Cita con resumen
Motte J, Trevathan E, Arvidsson JFV, Barreira MN, Mullens EL, Manasco P, and the Lamictal Lennox-Gastaut Study Group. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997;337:1807-12. [Ref.ID 36128]
19. Cita con resumen
Brodie MJ, Pellock J M. Taming the brain storms: felbamate updated. Lancet 1995;346:918-9. [Ref.ID 24912]
20. Cita con resumen
The Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993;328:29-33. [Ref.ID 18724]
Seleccionar todas
 1 a 20 de 20